Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 534,256 | 253,946 | 167,594 | 149,640 | 92,130 |
| Receivables | 827,343 | 832,873 | 881,967 | 774,414 | 732,907 |
| Inventories | 91,386 | 102,125 | 95,234 | 78,564 | 77,939 |
| Income taxes - deferred | 131,800 | 218,419 | 149,841 | 120,540 | 107,442 |
| TOTAL | $1,679,425 | $1,496,819 | $1,374,357 | $1,191,018 | $1,069,497 |
| Non-Current Assets | |||||
| PPE Net | 825,946 | 879,687 | 911,998 | 752,357 | 753,663 |
| Intangibles | 5,907,609 | 5,882,329 | 6,106,837 | 3,584,392 | 3,344,610 |
| Other Non-Current Assets | 150,663 | 144,995 | 172,501 | 133,715 | 138,345 |
| TOTAL | $6,884,218 | $6,907,011 | $7,191,336 | $4,470,464 | $4,236,618 |
| Total Assets | $8,563,643 | $8,403,830 | $8,565,693 | $5,661,482 | $5,306,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 170,507 | 5,142 | 163,581 | 316,874 | 336,839 |
| Accounts payable and accrued liabilities | 888,705 | 1,219,619 | 1,124,716 | 833,996 | 764,453 |
| TOTAL | $1,059,212 | $1,224,761 | $1,288,297 | $1,150,870 | $1,101,292 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,936,792 | 3,078,089 | 3,377,212 | 1,239,105 | 1,255,386 |
| Other Non-Current Liabilities | 519,064 | 444,141 | 549,432 | 252,336 | 186,453 |
| TOTAL | $3,492,967 | $3,553,935 | $3,953,154 | $1,491,441 | $1,441,839 |
| Total Liabilities | $4,552,179 | $4,778,696 | $5,241,451 | $2,642,311 | $2,543,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 178,917 | 190,575 | 194,149 | 193,622 | 198,394 |
| Common Shares | 2,141 | 2,141 | 2,137 | 2,138 | 2,137 |
| Retained earnings | 3,216,639 | 2,561,679 | 2,057,744 | 1,800,255 | 1,292,510 |
| Other shareholders' equity | 1,316 | -47,751 | 25,536 | -295 | -9,196 |
| TOTAL | $4,011,464 | $3,625,134 | $3,324,242 | $3,019,171 | $2,762,984 |
| Total Liabilities And Equity | $8,563,643 | $8,403,830 | $8,565,693 | $5,661,482 | $5,306,115 |